Company Overview
Snapshot
Founded in July 2020 by Vitali Binyaminov, MedicannX operates with 1–10 employees. The company has raised $18.95M across one funding round from Darwin Real Estate and Investments. In July 2024, MedicannX secured significant funding to advance its medical cannabis cultivation and product development.
Business overview
MedicannX is a medical cannabis company specializing in a unique aeroponic cultivation technology. The company develops medical products using an automated, oxygen-based aeroponic system housed in climate-controlled growing rooms. This technology allows for precise monitoring and cultivation independent of external weather conditions, serving the Health Tech & Life Sciences sector, particularly within the Pharma & Medical Biotechnology and Medical Cannabis industries.
Strategic signal
In July 2024, MedicannX announced a significant funding round, raising NIS 70 million (approximately $18.95 million). This capital infusion is a strong validation of the company's innovative aeroponic cultivation method for medical cannabis and signals investor confidence in its potential to develop advanced medical products within the Health Tech & Life Sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- What is MedicannX's core technology?
- MedicannX utilizes a unique aeroponic cultivation method based on oxygen use to grow cannabis. This automated system operates within climate-controlled growing rooms, independent of external weather conditions.
- When was MedicannX founded and by whom?
- MedicannX was founded in July 2020 by Vitali Binyaminov, who serves as the Founder & CEO.
- What significant funding did MedicannX receive recently?
- In July 2024, MedicannX raised NIS 70 million, equivalent to approximately $18.95 million USD, in a seed funding round from Darwin Real Estate and Investments.
- What markets does MedicannX target?
- MedicannX targets the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Medical Cannabis. It also operates within Agriculture & Food Technologies.
- What is the current product development stage for MedicannX?
- MedicannX is currently in the R&D stage for its products, focusing on developing medical cannabis products using its advanced cultivation technology.